Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Transcatheter Aortic Valve Replacement: A Real-World Propensity-Matched Analysis | Synapse
May 17, 2026Open Access
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Transcatheter Aortic Valve Replacement: A Real-World Propensity-Matched Analysis
Key Points
This research aims to evaluate how sodium-glucose cotransporter 2 inhibitors affect outcomes in patients undergoing transcatheter aortic valve replacement.
Conducted a propensity-matched analysis comparing outcomes in patients with and without sodium-glucose cotransporter 2 inhibitors.
Utilized real-world data to examine clinical endpoints post-transcatheter aortic valve replacement.
Patients receiving sodium-glucose cotransporter 2 inhibitors had improved post-surgical outcomes compared to those who did not, with statistical significance.
The analysis demonstrated a reduction in adverse events among patients taking sodium-glucose cotransporter 2 inhibitors.